Akari Therapeutics Plc (AKTX) — Institutional Holders, Q2 2026
9 institutional investment managers reported a AKTX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.5M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
AKTX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MMCAP International SPCNew · +100,000 sh+$1.0M
- JANE STREET GROUPNew · +15,463 sh+$158.4K
- HRT FINANCIALNew · +13,745 sh+$140.8K
- SBI Securities , Ltd.Added · +9 sh+$92.00
- Caitong International Asset Management , LtdNew · +8 sh+$82.00
Biggest sellers
- ARMISTICE CAPITALSold out · -38,922 sh-$398.8K
- MORGAN STANLEYSold out · -1 sh-$10.00
AKTX 13F holders ranked 1–9 of 9
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | MMCAP International SPC#1 · 100,000 sh | 100,000 | $1.0M | 0.09% | New |
| 2 | Cresset Asset Management#2 · 20,561 sh | 20,561 | $210.6K | <0.01% | 0.0% |
| 3 | JANE STREET GROUP#3 · 15,463 sh | 15,463 | $158.4K | 0.00% | New |
| 4 | HRT FINANCIAL#4 · 13,745 sh | 13,745 | $140.0K | <0.01% | New |
| 5 | IFP Advisors#5 · 181 sh | 181 | $1.9K | — | -97.6% |
| 6 | SBI Securities , Ltd.#6 · 14 sh | 14 | $143.00 | — | +180.0% |
| 7 | Caitong International Asset Management , Ltd#7 · 8 sh | 8 | $82.00 | 0.00% | New |
| 8 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#8 · 7 sh | 7 | $72.00 | 0.00% | New |
| 9 | Truvestments Capital#9 · 1 sh | 1 | $10.00 | 0.00% | 0.0% |
Funds that sold out of AKTX in Q2 2026 (2)
Held AKTX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| ARMISTICE CAPITAL38,922 sh | 38,922 | $200.4K |
| MORGAN STANLEY1 sh | 1 | $5.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.